Pancreatic Cancer Research

ResearcherThe Netherlands Cancer InstituteNo recent work listed

Emile E. Voest

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8249-9586; OpenAlex author ID A5060207753. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 trial · 2023: 1 paper

Papers 2

  1. Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma. Co-author DOI 10.1002/cam4.5893↗
  2. Intravital characterization of tumor cell migration in pancreatic cancer. Co-author DOI 10.1080/21659087.2016.1261773↗

Trials 1

  1. Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers Study director NCT04916236↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Luca Gianni · 1 shared paper, 2023 · strength 0.16
  2. Josep M. Tabernero · 1 shared paper, 2023 · strength 0.16
  3. Giuseppe Viale · 1 shared paper, 2023 · strength 0.16
  4. Elisabeth G.E. de Vries · 1 shared paper, 2023 · strength 0.16
  5. Evelyne Beerling · 1 shared paper, 2016 · strength 0.08
  6. Jacco van Rheenen · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.